Financial ResultsDec 18, 2025 · 3:59pm ET
INABIN8bio, Inc. Common Stock
IN8bio Announces $40.2 Million Private Placement to Advance INB-619
Proceeds will support IND application for novel gamma-delta T cell engager.
Financial ResultsDec 18, 2025 · 3:59pm ET
INABIN8bio, Inc. Common Stock+56.0%
IN8bio Announces $40.2 Million Private Placement to Advance INB-619